Correction to Lancet Oncol 2015; 16: 1479
- PMID: 27733289
- DOI: 10.1016/S1470-2045(16)30233-9
Correction to Lancet Oncol 2015; 16: 1479
Erratum for
-
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial.Lancet Oncol. 2015 Nov;16(15):1473-1482. doi: 10.1016/S1470-2045(15)00290-9. Epub 2015 Oct 22. Lancet Oncol. 2015. PMID: 26482279 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
